EMA Authorised: Eladynos (abaloparatide) — Theramex Ireland Limited

View source ↗

Summary

EMA has authorised Eladynos (abaloparatide) for osteoporosis, including postmenopausal osteoporosis, with Theramex Ireland Limited as the MAH.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Eladynos (abaloparatide)

Snippet

Status: Authorised. Therapeutic area: Osteoporosis, Postmenopausal;Osteoporosis. MAH: Theramex Ireland Limited. Decision date: 11/04/2024